Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

摘要

BackgroundAdjuvant therapy for T3N0 rectal cancer was controversial with respect to both radiation and the use of a combined regimen of chemotherapy. We evaluated both clinical features and biomarkers and sought to determine risk factors for those patients retrospectively.